
Managing Toxicities from Commonly Used Agents in Colorectal Cancer (CRC)
Terri Pollack, DNP, APRN, FNP, BA

Therapeutic Developments For Neuroendocrine Tumors of the GI Tract and Others
Robert Ramirez, DO, FACP

ER-PR Breast Disease - Early Stage, LocallyAdvanced and Metastatic Breast Cancer
Vicente Valero, MD, FACP

Handling the Most Common Toxicitiesfrom IO - Endocrinopathies,Pneumonitis, Skin Rash Pruritus and Adrenal Insufficiency
Laura J. Zitella, MS, RN, ACNP-BC, AOCN

Ovarian Cancer: Contemporary Management & Clinical Trial Endpoint Considerations
Thomas J. Herzog, MD